Evidence map›Paper›PMID 36100700›Full record

Trial reportClinical research in cardiology : official journal of the German Cardiac Society2023

Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease.

Michael Wester, Franziska Koll, Mark Luedde, Christoph Langer, Markus Resch, Andreas Luchner, Karolina Müller, Florian Zeman, Michael Koller, Lars S Maier and 1 more

Open access · hybridAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Clinical research in cardiology : official journal of the German Cardiac Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Michael WesterDepartment of Internal Medicine II, University Heart Centre Regensburg, University Medical Center Regensburg, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.ORCID http://orcid.org/0000-0001-7869-8363
Franziska KollDepartment of Internal Medicine II, University Heart Centre Regensburg, University Medical Center Regensburg, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Mark LueddeKardiologische Gemeinschaftspraxis Bremerhaven, Bremerhaven, Germany.
Christoph LangerKardiologisch-Angiologische Praxis, Heart Centre Bremen, Bremen, Germany.
Markus ReschDepartment of Internal Medicine I, St. Josef Hospital, Regensburg, Germany.
Andreas LuchnerDepartment of Cardiology, Hospital Barmherzige Brüder Regensburg, Regensburg, Germany.
Karolina MüllerCentre for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Florian ZemanCentre for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Michael KollerCentre for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Lars S MaierDepartment of Internal Medicine II, University Heart Centre Regensburg, University Medical Center Regensburg, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Samuel SossallaDepartment of Internal Medicine II, University Heart Centre Regensburg, University Medical Center Regensburg, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. samuel.sossalla@ukr.de.
University Hospital Regensburg · DEKrankenhaus Barmherzige Brüder · DESt. Josef-Hospital · DEUniversity of Bremen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDyspnea is a frequent symptom in patients with stable coronary artery disease (CAD) and is recognized as a possible angina equivalent.

objectivesThis study was to assess the impact of percutaneous coronary intervention (PCI) on dyspnea, quality of life, and angina pectoris in patients with stable CAD.

methodsThe prospective, multi-center PLA-pCi-EBO-pilot trial included 144 patients with symptomatic stable CAD and successful PCI. The prespecified endpoints angina pectoris (Seattle Angina Questionnaire-SAQ) and dyspnea (NYHA scale) were assessed 6 months after PCI. Predictors for symptomatic improvement were assessed with uni- and multivariable logistic regression analyses.

resultsPatients with concomitant dyspnea had worse SAQ physical limitation scores at baseline (49.5 ± 21.0 vs 58.9 ± 22.0, p = 0.013) but showed no difference for angina frequency or quality of life. Overall, symptomatic burden of angina pectoris and dyspnea was alleviated by PCI. However, patients with concomitant dyspnea had markedly worse scores for physical limitation (78.9 ± 25.0 vs 94.3 ± 10.6, p < 0.001), angina frequency (77.9 ± 22.8 vs 91.1 ± 12.4, p < 0.001), and quality of life (69.4 ± 24.1 vs 82.5 ± 14.4, p < 0.001) after PCI. The prevalence of dyspnea (NYHA class ≥ 2) declined from 73% before PCI to 54%. Of 95 initially dyspneic patients, 57 (60%) improved at least one NYHA class 6 months after PCI. In a multivariable logistic regression analysis, "atypical angina pectoris" was associated with improved NYHA class, whereas "diabetes mellitus" had a negative association.

conclusionPCI effectively reduced dyspnea, which is a frequent and demanding symptom in patients with CAD. The German Clinical Trials Register registration number is DRKS0001752 ( www.drks.de ).

Indexed as

Coronary Artery DiseasePercutaneous Coronary InterventionAngina PectorisDyspneaHealth StatusHumansProspective StudiesQuality of LifeTreatment OutcomeDyspneaPCIPLA-pCi-EBOQoLStable CAD

Identifiers

PMID36100700
PMCPMC10449717
OpenAlexW4295755237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.